Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2049249

Increments in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal women

Author
STOCK, J. L1 ; BELL, N. H2 ; WEI, L9 ; SANTORA, A. C9 ; CHESNUT, C. H3 ; ENSRUD, K. E4 ; GENANT, H. K5 ; HARRIS, S. T5 ; MCCLUNG, M. R6 ; SINGER, F. R7 ; YOOD, R. A8 ; PRYOR-TILLOTSON, S9
[1] Memorial Health Care and the University of Massachusetts Medical School, Worcester, Massachusetts, United States
[2] VA Medical Center and the Medical University of South Carolina, Charleston, South Carolina, United States
[3] University of Washington, Seattle, Washington, United States
[4] Minneapolis VA Medical Center and Healthspan, Inc., Minneapolis, Minnesota, United States
[5] University of California, San Francisco, California, United States
[6] Providence Medical Center, Portland, Oregon, United States
[7] St. John's Hospital and Health Center, Santa Monica, California, United States
[8] St. Vincent Hospital, Worcester, Massachusetts, United States
[9] Merck Research Laboratories, Rahway, New Jersey, United States
Conference name
Annual Meeting of the Society for Bone and Mineral Research (17 ; Baltimore, MD 1995-11) = World Congress on Osteoporosis (Amsterdam 1995-11)
Source

The American journal of medicine. 1997, Vol 103, Num 4, pp 291-297 ; ref : 22 ref

CODEN
AJMEAZ
ISSN
0002-9343
Scientific domain
General medicine general surgery
Publisher
Elsevier, New York, NY
Publication country
United States
Document type
Conference Paper
Language
English
Keyword (fr)
Arrêt traitement Bisphosphonates Chimiothérapie Efficacité traitement Essai clinique Estimation paramètre Femelle Hanche Homme Masse osseuse Ostéoporose Placebo Postménopause Pronostic Rachis lombaire Traitement Alendronate Os Ostéopathie Système ostéoarticulaire pathologie
Keyword (en)
Withdrawal Bisphosphonates Chemotherapy Treatment efficiency Clinical trial Parameter estimation Female Hip Human Bone mass Osteoporosis Placebo Postmenopause Prognosis Lumbar spine Treatment Bone Bone disease Diseases of the osteoarticular system
Keyword (es)
Paro tratamiento Bisfosfonatos Quimioterapia Eficacia tratamiento Ensayo clínico Estimación parámetro Hembra Cadera Hombre Masa oseosa Osteoporosis Placebo Postmenopausia Pronóstico Raquis lumbar Tratamiento Hueso Osteopatía Sistema osteoarticular patología
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02L Bones, joints and connective tissue. Antiinflammatory agents

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
2049249

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web